Divalproex sodium is the same medication as Depakote. Depakote is the brand name, and divalproex sodium is its generic equivalent. Both contain the identical active ingredient: a compound made of sodium valproate and valproic acid bonded together in equal parts. The FDA has approved generic divalproex sodium, so you can get this medication under either name.
What Divalproex Sodium Actually Is
Divalproex sodium is a coordination compound, meaning two molecules are chemically linked into one stable form. Specifically, it pairs sodium valproate with valproic acid in a 1:1 ratio. Once absorbed, it breaks down into valproic acid, which is the substance that does the therapeutic work in your body. Whether the tablet says “Depakote” or “divalproex sodium” on the label, the same active compound enters your bloodstream and produces the same effects.
The FDA has approved divalproex sodium for three uses: treating manic episodes in bipolar disorder, controlling certain types of seizures (including complex partial seizures and absence seizures), and preventing migraine headaches.
The Two Formulations and Why They Matter
This is where things get slightly more complicated. Divalproex sodium comes in two distinct formulations, and they are not interchangeable at the same dose.
Delayed-release (DR) is the original Depakote formulation. It’s typically taken two or three times per day. The tablet has an enteric coating that delays absorption until it reaches the small intestine.
Extended-release (ER) is sold as Depakote ER and uses a polymer matrix system that slowly releases the drug across the stomach, small intestine, and large intestine over 18 to 24 hours. This allows once-daily dosing and produces smoother, more consistent blood levels throughout the day, with lower peak concentrations and smaller swings between the highest and lowest levels.
The key distinction: the ER formulation is roughly 8 to 20% less bioavailable than the DR version. That means your body absorbs somewhat less of the drug from an ER tablet. If you’re switching from DR to ER, the ER dose typically needs to be 8 to 20% higher to maintain equivalent blood levels. This isn’t something to adjust on your own, since individual responses vary. Some people see significantly lower trough levels after switching, even at the adjusted dose.
Generic vs. Brand: Cost and Equivalence
The price difference between brand-name Depakote and generic divalproex sodium is substantial. At retail prices without insurance, brand-name Depakote runs around $4.22 per tablet for a 250 mg delayed-release dose, totaling about $422 for 100 tablets. Generic divalproex sodium can cost as little as $0.30 per tablet, or roughly $30 for 100 tablets of the 500 mg extended-release version. That’s a tenfold difference or more, depending on the strength and formulation.
Generic medications must meet FDA bioequivalence standards, meaning they deliver the same amount of active drug into the bloodstream at the same rate as the brand-name version. For most people, switching between brand and generic produces no noticeable difference. However, because divalproex has a defined therapeutic window (blood levels between 50 and 100 micrograms per milliliter), some clinicians recommend checking blood levels after a switch to confirm you’re still in range, particularly for seizure control where small changes can matter.
Important Safety Considerations
Regardless of whether you take brand or generic, divalproex sodium carries the same serious warnings. The FDA requires three boxed warnings on its label, the most prominent safety alerts a drug can have.
The first involves liver damage. Fatal liver failure has occurred in patients taking this medication, most often within the first six months of treatment. Early warning signs include unusual tiredness, weakness, facial swelling, loss of appetite, and vomiting. Children under two years old face the highest risk, especially those taking multiple seizure medications or those with certain metabolic disorders. People with mitochondrial DNA disorders affecting a specific enzyme (POLG mutations) should not take this medication at all due to the risk of acute liver failure.
The second warning concerns pregnancy. Valproic acid, the active form of this drug, can cause major birth defects, particularly neural tube defects like spina bifida. It can also lower IQ scores and cause neurodevelopmental problems in children exposed during pregnancy. For migraine prevention specifically, divalproex is contraindicated in pregnant women and in women of childbearing potential who aren’t using effective contraception. For epilepsy and bipolar disorder, it should only be used during pregnancy when other treatments have failed.
The third warning involves pancreatitis, a potentially life-threatening inflammation of the pancreas that can occur at any point during treatment.
What Monitoring Looks Like
If you’re taking divalproex in any form, periodic blood tests are part of the process. The therapeutic blood level is 50 to 100 micrograms per milliliter. Below that range, the medication may not be effective. Above 100, the risk of side effects climbs, including drowsiness, confusion, and liver problems. Liver function tests are standard before starting treatment and at regular intervals afterward, particularly during the first six months.
Blood level monitoring becomes especially relevant if you switch formulations (DR to ER) or switch between brand and generic versions. Individual absorption can vary enough that a dose that worked perfectly in one formulation may need adjustment in another. If your seizure control changes, your mood shifts, or your migraines return after a switch, a blood level check can quickly reveal whether the new formulation is delivering the same drug exposure you had before.